Taniguchi Kosuke, Inoue Mikihiro, Arai Katsuhiro, Uchida Keiichi, Migita Osuke, Akemoto Yui, Hirayama Junya, Takeuchi Ichiro, Shimizu Hirotaka, Hata Kenichiro
Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Tokyo, 157-8535, Japan.
Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Tsu, Mie, 514-8507, Japan.
Hum Genome Var. 2021 Jan 14;8(1):1. doi: 10.1038/s41439-020-00128-4.
A20 haploinsufficiency (HA20), a disease caused by loss-of-function TNFAIP3 mutations, manifests various autoinflammatory and/or autoimmune symptoms. Some cases of HA20 were initially diagnosed as very early onset inflammatory bowel disease (VEO-IBD). We performed whole-exome sequencing (WES) for a Japanese girl with infantile-onset IBD and a severe perianal lesion and detected a novel de novo 119 kb microdeletion containing only TNFAIP3 (arr[GRCh37] 6q23.3(138125829_138244816) × 1).
A20单倍体不足(HA20)是一种由功能丧失性TNFAIP3突变引起的疾病,表现出各种自身炎症和/或自身免疫症状。一些HA20病例最初被诊断为极早发型炎症性肠病(VEO-IBD)。我们对一名患有婴儿期发病的IBD和严重肛周病变的日本女孩进行了全外显子组测序(WES),并检测到一个仅包含TNFAIP3的新的新生119 kb微缺失(arr[GRCh37] 6q23.3(138125829_138244816)×1)。